SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001085146-24-001429
Filing Date
2024-02-14
Accepted
2024-02-14 16:02:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 683 CAPITAL MANAGEMENT, LLC cldia2_21424.htm SC 13G/A 43443
  Complete submission text file 0001085146-24-001429.txt   45179
Mailing Address 1700 BROADWAY SUITE 4200 NEW YORK NY 10019
Business Address 1700 BROADWAY SUITE 4200 NEW YORK NY 10019 (212) 554-2379
683 Capital Management, LLC (Filed by) CIK: 0001404574 (see all company filings)

IRS No.: 205100992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Subject) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92875 | Film No.: 24637562
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)